Cookie Policy

DNAtrix, Inc.

Filing Date
November 16, 2022
Case Number
22-11193
District
District of Delaware

Assets: $1M-$10M

Liabilities: $1M-$10M

Subchapter_V
Docket

On November 16, 2022 DNAtrix, Inc. filed for chapter 11 protection in the District of Delaware (Case No. 22-11193). The Debtor reports Assets of $1M-$10M and Liabilities of $1M-$10M. The Petition states funds will be available to Unsecured Creditors.

Per Claims Agent:
Debtor Represented by:

David M. Klauder

Bielli & Klauder, LLC


Company Information:
Address:

2659 State Street

#1023

Carlsbad, CA 92008

Map to Debtor
Website:
https://www.dnatrix.com
Description:
DNAtrix is a clinical stage, biotechnology company developing virus-driven immunotherapies for cancer. DNAtrix’s lead product, DNX-2401, is a modified common cold virus that targets and kills cancer cells selectively.
Industry:
Biotechnology

Share this Filing

Press Release:
Note: we do not represent the Debtor in this case and this information is obtained from automated sources and may not be 100% accurate.
Petition image
Petition
Computer image
New! Dockets